{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T10:33:50Z","timestamp":1787222030116,"version":"build-2736575974"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T00:00:00Z","timestamp":1655769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The literature suggests that stress may play a pivotal role in the precipitation of acute central serous chorioretinopathy (CSC) because chorioretinal integrity can be affected by the psychosocial state of the patient, indicating the need for a biomarker. Not only physical stress but also psychological stress causes many types of physical disorders. However, little is known about the pathophysiology of stress-induced disease. The objective of this study was to investigate whether serum factors might be involved in the development of stress-induced ocular diseases.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This observational case series included 33 eyes of 33 consecutive patients with treatment-na\u00efve acute CSC. Fifty eyes of 50 age-matched healthy volunteers were included in this study as non-CSC controls. Serum samples were collected from all participants, and the levels of mitochondrial DNA (mtDNA) were measured by quantitative real-time (RT)-PCR. Serum levels of high-mobility group box (HMGB) 1 and 8-hydroxy-2\u2032-deoxyguanosine (8-OHdG), biological markers of acute\/chronic inflammation and oxidative stress, were also measured. The relationships between serum mtDNA, 8-OHdG, and HMGB1 concentrations were investigated by multivariate regression analysis, alongside an assessment of clinical data.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In the treatment-na\u00efve acute CSC group, the serum mtDNA levels (36.5 \u00b1 32.4 ng\/mL) were significantly higher than the levels in the control group (7.4 \u00b1 5.9 ng\/mL; <jats:italic>p<\/jats:italic> &amp;lt; 0.001). Serum levels of 8-OHdG and HMGB1 in treatment-na\u00efve acute CSC patients measured 0.12 \u00b1 0.08 ng\/mL and 18.1 \u00b1 35.0 ng\/mL, respectively, indicating that HMGB1 levels were elevated in CSC compared with the control group. Multivariable regression analysis demonstrated that increased serum mtDNA levels were significantly associated with the height of serous retinal detachment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>We showed serum mtDNA and HMGB1 level elevation and its relation to the clinical activities of CSC, indicating that serum mtDNA and HMGB1 could serve as biomarkers for the acute phase of the disease. The use of these biomarkers makes it possible to predict disease onset and determine disease severity.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.938600","type":"journal-article","created":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T05:46:23Z","timestamp":1655790383000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Mitochondrial DNA as a Biomarker for Acute Central Serous Chorioretinopathy: A Case-Control Study"],"prefix":"10.3389","volume":"9","author":[{"given":"Noriyasu","family":"Hashida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunobu","family":"Asao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikako","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Quantock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryotaro","family":"Saita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kurakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuichi","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohji","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41380-019-0585-z","article-title":"Prospective biomarkers of major depressive disorder: a systematic review and meta-analysis.","volume":"25","author":"Kennis","year":"2020","journal-title":"Mol Psychiatry."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2019.00091","article-title":"Biomarkers in stress related diseases\/disorders: diagnostic, prognostic, and therapeutic values.","volume":"6","author":"Dhama","year":"2019","journal-title":"Front Mol Biosci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/00006982-198700720-00009","article-title":"Type-A behavior and central serous chorioretinopathy.","volume":"7","author":"Yannuzzi","year":"1987","journal-title":"Retina."},{"key":"B4","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1176\/ajp.144.1.46","article-title":"Loss of vision due to central serous chorioretinopathy following psychological stress.","volume":"144","author":"Gelber","year":"1987","journal-title":"Am J Psychiatry."},{"key":"B5","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1136\/bjo.81.11.962","article-title":"Endogenous cortisol profile in patients with central serous chorioretinopathy.","volume":"81","author":"Garg","year":"1997","journal-title":"Br J Ophthalmol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1016\/s0161-6420(02)01303-9","article-title":"Involvement of corticosteroids and catecholamines in the pathogenesis of central serous chorioretinopathy: a rationale for new treatment strategies.","volume":"109","author":"Jampol","year":"2002","journal-title":"Ophthalmology."},{"key":"B7","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/s0161-6420(95)30960-8","article-title":"Bilateral bullous exudative retinal detachment complicating idiopathic central serous chorioretinopathy during systemic corticosteroid therapy.","volume":"102","author":"Gass","year":"1995","journal-title":"Ophthalmology."},{"key":"B8","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1001\/archopht.1991.01080050091036","article-title":"Central serous chorioretinopathy and white subretinal exudation during pregnancy.","volume":"109","author":"Gass","year":"1991","journal-title":"Arch Ophthalmol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ophtha.2003.09.024","article-title":"Risk factors for central serous chorioretinopathy: a case-control study.","volume":"111","author":"Haimovici","year":"2004","journal-title":"Ophthalmology."},{"key":"B10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/IAE.0000000000000837","article-title":"Risk factors for central serous chorioretinopathy: a systematic Review and Meta-Analysis.","volume":"36","author":"Liu","year":"2016","journal-title":"Retina."},{"key":"B11","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.preteyeres.2015.05.003","article-title":"Central serous chorioretinopathy: recent findings and new physiopathology hypothesis.","volume":"48","author":"Daruich","year":"2015","journal-title":"Prog Retin Eye Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1136\/bjophthalmol-2012-302349","article-title":"Macular choroidal blood flow velocity decreases with regression of acute central serous chorioretinopathy.","volume":"97","author":"Saito","year":"2013","journal-title":"Br J Ophthalmol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"6515","DOI":"10.1167\/iovs.15-17246","article-title":"Pulse waveform changes in macular choroidal hemodynamics with regression of acute central serous chorioretinopathy.","volume":"56","author":"Saito","year":"2015","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000055622","article-title":"Regulatory mechanisms in the retinal and choroidal circulation.","volume":"32","author":"Delaey","year":"2000","journal-title":"Ophthalmic Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1097\/00006982-200512000-00006","article-title":"Acute central serous chorioretinopathy and fundus autofluorescence.","volume":"25","author":"Eandi","year":"2005","journal-title":"Retina J Retinal Vitreous Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature09663","article-title":"A role for mitochondria in NLRP3 inflammasome activation.","volume":"469","author":"Zhou","year":"2011","journal-title":"Nature."},{"key":"B17","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/nri.2017.21","article-title":"Mitochondrial DNA in innate immune responses and inflammatory pathology.","volume":"17","author":"West","year":"2017","journal-title":"Nat Rev Immunol."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/4050796","article-title":"The role of mitochondrial damage-associated molecular patterns in chronic neuroinflammation.","volume":"2019","author":"Bajwa","year":"2019","journal-title":"Mediat Inflamm."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/cells8040328","article-title":"Circulating cell-free mtDNA contributes to AIM2 inflammasome-mediated chronic inflammation in patients with type 2 diabetes.","volume":"8","author":"Bae","year":"2019","journal-title":"Cells."},{"key":"B20","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.oret.2016.09.003","article-title":"Reduced blood serotonin levels in chronic central serous chorioretinopathy.","volume":"1","author":"Sakai","year":"2017","journal-title":"Ophthalmol Retina."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.jcrc.2013.05.006","article-title":"Plasma mitochondrial DNA levels in patients with trauma and severe sepsis: time course and the association with clinical status.","volume":"28","author":"Yamanouchi","year":"2013","journal-title":"J Crit Care."},{"key":"B22","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/nrc3066","article-title":"Cell-free nucleic acids as biomarkers in cancer patients.","volume":"11","author":"Schwarzenbach","year":"2011","journal-title":"Nat Rev Cancer."},{"key":"B23","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.psyneuen.2019.03.026","article-title":"Acute psychological stress increases serum circulating cell-free mitochondrial DNA.","volume":"106","author":"Trumpff","year":"2019","journal-title":"Psychoneuroendocrinology."},{"key":"B24","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.mito.2021.04.002","article-title":"Stress and circulating cell-free mitochondrial DNA: a systematic review of human studies, physiological considerations, and technical recommendations.","volume":"59","author":"Trumpff","year":"2021","journal-title":"Mitochondrion."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/j.metabol.2009.05.024","article-title":"Factors associated with serum high mobility group box 1 (HMGB1) levels in a general population.","volume":"58","author":"Fukami","year":"2009","journal-title":"Metabolism."},{"key":"B26","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1017\/s0033291702006074","article-title":"Short screening scales to monitor population prevalences and trends in non-specific psychological distress.","volume":"32","author":"Kessler","year":"2002","journal-title":"Psychol Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00417-011-1910-7","article-title":"Choroidal observations in Vogt-Koyanagi-Harada disease using high-penetration optical coherence tomography.","volume":"250","author":"Nakai","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics.","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplantat."},{"key":"B29","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1002\/1873-3468.12956","article-title":"Mitochondrial DNA damage and reactive oxygen species in neurodegenerative disease.","volume":"592","author":"Nissanka","year":"2018","journal-title":"FEBS Lett."},{"key":"B30","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1146\/annurev.immunol.21.120601.141126","article-title":"Toll-like receptors.","volume":"21","author":"Takeda","year":"2003","journal-title":"Annu Rev Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity.","volume":"124","author":"Akira","year":"2006","journal-title":"Cell."},{"key":"B32","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nature08780","article-title":"Circulating mitochondrial DAMPs cause inflammatory responses to injury.","volume":"464","author":"Zhang","year":"2010","journal-title":"Nature."},{"key":"B33","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1001\/jama.1992.03490240060037","article-title":"Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome).","volume":"268","author":"Bone","year":"1992","journal-title":"JAMA."},{"key":"B34","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/35047123","article-title":"A Toll-like receptor recognizes bacterial DNA.","volume":"408","author":"Hemmi","year":"2000","journal-title":"Nature."},{"key":"B35","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.it.2011.01.005","article-title":"Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation.","volume":"32","author":"Krysko","year":"2011","journal-title":"Trends Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.mito.2018.07.008","article-title":"Cell-free mitochondrial DNA in progressive multiple sclerosis.","volume":"46","author":"Lowes","year":"2019","journal-title":"Mitochondrion."},{"key":"B37","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.exer.2015.06.012","article-title":"Expression of Toll-like receptors in human retinal and choroidal vascular endothelial cells.","volume":"138","author":"Stewart","year":"2015","journal-title":"Exp Eye Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/s1383-5742(97)00035-5","article-title":"Analysis of a form of oxidative DNA damage, 8-hydroxy-2\u2019-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis.","volume":"387","author":"Kasai","year":"1997","journal-title":"Mutat Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nrrheum.2011.222","article-title":"HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease.","volume":"8","author":"Harris","year":"2012","journal-title":"Nat Rev Rheumatol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/ni1457","article-title":"Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE.","volume":"8","author":"Tian","year":"2007","journal-title":"Nat Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"3474","DOI":"10.1167\/iovs.05-1246","article-title":"Sympathetic-parasympathetic activity and reactivity in central serous chorioretinopathy: a case-control study.","volume":"47","author":"Tewari","year":"2006","journal-title":"Investig Ophthalmol Vis Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jhep.2015.02.009","article-title":"Hypoxia induced HMGB1 and mitochondrial DNA interactions mediate tumor growth in hepatocellular carcinoma through Toll-like receptor 9.","volume":"63","author":"Liu","year":"2015","journal-title":"J Hepatol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1038\/eye.2010.130","article-title":"Central serous chorioretinopathy: an update on pathogenesis and treatment.","volume":"24","author":"Gemenetzi","year":"2010","journal-title":"Eye."},{"key":"B44","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S0140-6736(19)32981-2","article-title":"Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial.","volume":"395","author":"Lotery","year":"2020","journal-title":"Lancet."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17091425","article-title":"Intra-peritoneal administration of mitochondrial DNA provokes acute lung injury and systemic inflammation via toll-like receptor 9.","volume":"17","author":"Zhang","year":"2016","journal-title":"Int J Mol Sci."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.938600\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T05:46:27Z","timestamp":1655790387000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.938600\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,21]]},"references-count":45,"alternative-id":["10.3389\/fmed.2022.938600"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.938600","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,21]]},"article-number":"938600"}}